Douglas J. Hartman

5.8k citations

117 papers · 3.4k indexed · h-index 32

Health Informatics top 1%
Biophysics top 1%
Oncology top 5%
- Colorectal Cancer Treatments and Studies 10
- Cancer Immunotherapy and Biomarkers 10
Cancer Research top 5%
Psychiatry and Mental health top 5%
Genetics
- Inflammatory Bowel Disease 26
Artificial Intelligence
- AI in cancer detection 22
Epidemiology
- Microscopic Colitis 10
Surgery
- Eosinophilic Esophagitis 8
Radiology, Nuclear Medicine and Imaging
- Radiomics and Machine Learning in Medical Imaging 8
Pathology and Forensic Medicine
- Genetic factors in colorectal cancer 7

Co-authors: Liron Pantanowitz Alyssa M. Krasinskas Anil V. Parwani Brian M. Davis Kathryn M. Albers Gregory T. MacLennan Mark D. Zarella Marilyn M. Bui
Cited by: Health Informatics Biophysics Oncology
Journals: Proceedings of the National Academy of Sciences (3 papers)Nucleic Acids Research (1 paper)Journal of Clinical Investigation (1 paper)
Partner nations: United States Italy Australia

In The Last Decade

Douglas J. Hartman

115 papers receiving 3.4k citations

Peers

Countries citing papers authored by Douglas J. Hartman

Since Specialization

Citations

This map shows the geographic impact of Douglas J. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Hartman more than expected).

Fields of papers citing papers by Douglas J. Hartman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Hartman. The network helps show where Douglas J. Hartman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Douglas J. Hartman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas J. Hartman Line = papers co-authored together Douglas J. Hartman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer Cancer Prevention Research ·Jian‐Min Yuan,Thomas W. Kensler,Sanja Đačić,Douglas J. Hartman,Renwei Wang,Paula A. Balogh,Pamela Sufka,Melissa A. Turner,Kimberly Fuhrer,Lindsey Seigh,Yen Thi‐Hai Pham,Jennifer Adams‐Haduch,Giuseppe Valacchi,Shivendra V. Singh,James G. Herman,David O. Wilson	2025	3
2	Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy The Oncologist ·Dylan D. Fortman,Arivarasan Karunamurthy,Douglas J. Hartman,Hong Wang,Lindsey Seigh,Ibrahim Abukhiran,Yana G. Najjar,Liron Pantanowitz,Hassane M. Zarour,John M. Kirkwood,Diwakar Davar	2024	4
3	Granuloma Presence at Initial Surgery Predicts Need for Repeat Surgery Independent of Rutgeerts Score in Crohn’s Disease Inflammatory Bowel Diseases ·Furkan U. Ertem,Claudia Ramos Rivers,Andrew Watson,Gong Tang,Marc Schwartz,Elyse Johnston,Arthur Barrie,Ewen M. Harrison,Jeffrey Dueker,Douglas J. Hartman,David G. Binion	2023	2
4	SPaRTAN, a computational framework for linking cell-surface receptors to transcriptional regulators Nucleic Acids Research ·Xiaojun Ma,Ashwin Somasundaram,Zengbiao Qi,Douglas J. Hartman,Harinder Singh,Hatice U. Osmanbeyoglu	2021	6
5	Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer EBioMedicine ·Changqing Ma,Chad Storer,Uma Chandran,William A. LaFramboise,Patricia Petrosko,Madison Frank,Douglas J. Hartman,Liron Pantanowitz,Talin Haritunians,Richard D. Head,Ta‐Chiang Liu	2021	17
6	Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters Histopathology ·Reetesh K. Pai,Douglas J. Hartman,David F. Schaeffer,Christophe Rosty,Sameer Shivji,Richard Kirsch,Rish K. Pai	2021	35
7	Validated Indices for Histopathologic Activity Predict Development of Colorectal Neoplasia in Ulcerative Colitis Journal of Crohn s and Colitis ·Rish K. Pai,Douglas J. Hartman,Jonathan A. Leighton,Shabana F. Pasha,Claudia Ramos Rivers,Miguel Regueiro,David G. Binion,Reetesh K. Pai	2021	3
8	Su1867 BIG DATA ANALYTICS DEMONSTRATE A NOVEL, UNEXPECTED ASSOCIATION OF LOW SERUM IGG4 ANTIBODIES WITH INCREASED DISEASE SEVERITY IN 20% OF IBD PATIENTS Gastroenterology ·Filippos Koutroumpakis,Anna Evans Phillips,Dhiraj Yadav,Maaz Ahsan,Claudia Ramos Rivers,Jorge D. Machicado,Xiaoqing Tan,Siobhan Proksell,Elyse Johnston,Jeffrey Dueker,Hassieb Din,Hashash Jana,Gong Tang,Dmitriy Babichenko,Arthur Barrie,Douglas J. Hartman,Liza Konnikova,Michael A. Dunn,David G. Binion	2020	1
9	Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma Modern Pathology ·Lama Farchoukh,Douglas J. Hartman,Changqing Ma,James Celebrezze,David Medich,Nathan Bahary,Madison Frank,Liron Pantanowitz,Reetesh K. Pai	2020	29
10	Three-Dimensional Nanoscale Nuclear Architecture Mapping of Rectal Biopsies Detects Colorectal Neoplasia in Patients with Inflammatory Bowel Disease Cancer Prevention Research ·Shikhar Uttam,Jana G. Hashash,Justin LaFace,David G. Binion,Miguel Regueiro,Douglas J. Hartman,Randall E. Brand,Yang Liu	2019	9
11	Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon Cancer Cancer Immunology Research ·Michael Kvorjak,Yasmine Ahmed,Michelle L. Miller,Raahul Sriram,Claudia Coronnello,Jana G. Hashash,Douglas J. Hartman,Cheryl A. Telmer,Nataša Miškov-Živanov,Olivera J. Finn,Sandra Cascio	2019	72
12	Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis Clinical Gastroenterology and Hepatology ·Rish K. Pai,Douglas J. Hartman,Claudia Ramos Rivers,Miguel Regueiro,Marc Schwartz,David G. Binion,Reetesh K. Pai	2019	49
13	Improving Medical Students’ Understanding of Pediatric Diseases through an Innovative and Tailored Web-based Digital Pathology Program with Philips Pathology Tutor (Formerly PathXL) Journal of Pathology Informatics ·Cathy P. Chen,Bradley M Clifford,Matthew J O’Leary,Douglas J. Hartman,Jennifer Picarsic	2019	3
14	IBD LIVE Case Series–Case 4 Inflammatory Bowel Diseases ·Abhishek Gulati,Kofi Clarke,Julia B. Greer,David G. Binion,Myron Brand,Francis A. Farraye,Raymond K. Cross,Leonard Baidoo,Wolfgang H. Schraut,Douglas J. Hartman,Miguel Regueiro	2016	1
15	Early Prediction of Cancer Progression by Depth-Resolved Nanoscale Mapping of Nuclear Architecture from Unstained Tissue Specimens Cancer Research ·Shikhar Uttam,Hoa V. Pham,Justin LaFace,Brian J. Leibowitz,Jian Yu,Randall E. Brand,Douglas J. Hartman,Yang Liu	2015	43
16	Neuroplastic Changes Occur Early in the Development of Pancreatic Ductal Adenocarcinoma Cancer Research ·Rachelle E. Stopczynski,Daniel P. Normolle,Douglas J. Hartman,Haoqiang Ying,Jennifer J. DeBerry,Klaus Bielefeldt,Andrew D. Rhim,Ronald A. DePinho,Kathryn M. Albers,Brian M. Davis	2014	143
17	Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix Human Pathology ·Rish K. Pai,(unknown),Douglas J. Hartman,David Hernández Gonzalo,Keith Lai,Erinn Downs‐Kelly,John R. Goldblum,Xiuli Liu,Deepa T. Patil,Ana E. Bennett,Thomas Plesec,Shih–Fan Kuan,Marina N. Nikiforova,Bonnie Shadrach,Reetesh K. Pai	2013	46
18	Mucosal IgG4 Cell Infiltration in Ulcerative Colitis Is Linked to Disease Activity and Primary Sclerosing Cholangitis Inflammatory Bowel Diseases ·Amit Raina,Dhiraj Yadav,Miguel Regueiro,Alyssa M. Krasinskas,Melissa Saul,Dee Ann M. Sapienza,David G. Binion,Douglas J. Hartman	2013	20
19	Lynch syndrome–associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach Human Pathology ·Douglas J. Hartman,Randall E. Brand,Huankai Hu,Nathan Bahary,Beth Dudley,Simion I. Chiosea,Marina N. Nikiforova,Reetesh K. Pai	2013	24
20	Recurrent Blood Eosinophilia in Ulcerative Colitis Is Associated with Severe Disease and Primary Sclerosing Cholangitis Digestive Diseases and Sciences ·Arthur Barrie,Marwa El Mourabet,Katherine A. Weyant,Kofi Clarke,Mahesh Gajendran,Claudia Ramos Rivers,Seo Young Park,Douglas J. Hartman,Melissa Saul,Miguel Regueiro,Dhiraj Yadav,David G. Binion	2012	35

About Douglas J. Hartman

Douglas J. Hartman is a scholar working on Biophysics, Oncology and Genetics, having authored 117 papers that have together received 3.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (26 papers), AI in cancer detection (22 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Microscopic Colitis (10 papers), Eosinophilic Esophagitis (8 papers), Radiomics and Machine Learning in Medical Imaging (8 papers) and Genetic factors in colorectal cancer (7 papers). The work is most often cited by research in Health Informatics (88 citations), Biophysics (245 citations) and Oncology (909 citations). Douglas J. Hartman has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Liron Pantanowitz, Alyssa M. Krasinskas, Anil V. Parwani, Brian M. Davis, Kathryn M. Albers, Gregory T. MacLennan, Mark D. Zarella, Marilyn M. Bui, Andrew D. Rhim and Famke Aeffner. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact